Approved IND for Alligator Bioscience's CD40-targeting antibody mitazalimab

Corporate Breaking News

Home : Approved IND for Alligator Bioscience's CD40-targeting antibody mitazalimab

Dec 04 2020	Approved IND for Alligator Bioscience's CD40-targeting antibody mitazalimab
LUND, Sweden, Dec. 4, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced an approved IND (Investigational new Drug) for the CD40 targeting antibody mitazalimab. IND approval by the US Food and Drug Administration (FDA) is a prerequisite to start clinical...


Source:https://www.prnewswire.com:443/news-releases/approved-ind-for-alligator-biosciences-cd40-targeting-antibody-mitazalimab-301186398.html

Related News
» Skanska invests in land in Massachusetts, USA, for USD 177M, about SEK 1.5 billion » Investor Alert: Ademi LLP Investigates Possible Securities Fraud of Splunk Inc.